Market Research Report
Left Atrial Appendage Closure Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Endocardial Device Market and Epicardial Device Market
|Left Atrial Appendage Closure Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Endocardial Device Market and Epicardial Device Market|
Published: May 11, 2021
iData Research Inc.
Delivery time: 1-2 business days
Throughout this medical market research, the publisher analyzed Left Atrial Appendage Closure Device companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.
Left Atrial Appendage Closure Device Market Insights
The global left atrial appendage closure device (LAA) market size is estimated to increase over the forecast period to exceed $2.2 billion by 2027.
Boston Scientific, Abbott, and AtriCure are the share leaders within the global left atrial appendage closure device market. The global analysis covers over 70 countries and includes the endocardial device market and the epicardial device market.
Left atrial appendage closure devices were developed as an alternative method of reducing the risk of stroke in atrial fibrillation patients. LAA closure devices are used to seal off the LAA, preventing clot formation in the LAA and eliminating the need for the patient to take blood-thinning medication. With the prevalence of atrial fibrillation increasing over the forecast period, competitors within the space are funding trials and studies proving the safety and effectiveness of their respective devices.
Research Regional Coverage
Throughout this research series, the publisher has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are: